Funding for this research was provided by:
Norges Forskningsråd (276082, 323961)
Received: 30 August 2021
Accepted: 1 June 2022
First Online: 15 June 2022
: O.A.A. has received speaker’s honorarium from Lundbeck and Sunovion, and is a consultant to HealthLytix. A.M.D. is a Founder of and holds equity in CorTechs Labs, Inc., and serves on its Scientific Advisory Board. The terms of this arrangement have been reviewed and approved by UCSD in accordance with its competing interest policies. Other authors report no competing interests.